Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,269 | 653 | 40.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,000 | 8 | 27.9% |
| Consulting Fee | $5,750 | 3 | 22.9% |
| Travel and Lodging | $1,090 | 4 | 4.3% |
| Education | $1,019 | 11 | 4.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $9,331 | 49 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $4,814 | 35 | $0 (2024) |
| Janssen Biotech, Inc. | $2,379 | 221 | $0 (2024) |
| ABBVIE INC. | $1,582 | 89 | $0 (2024) |
| Journey Medical Corporation | $1,529 | 14 | $0 (2023) |
| GENZYME CORPORATION | $612.27 | 24 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $550.04 | 34 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $542.95 | 20 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $479.48 | 17 | $0 (2024) |
| Lilly USA, LLC | $470.87 | 29 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,514 | 211 | Janssen Biotech, Inc. ($748.43) |
| 2023 | $7,619 | 189 | Arcutis Biotherapeutics, Inc. ($4,658) |
| 2022 | $5,931 | 151 | UCB, Inc. ($3,861) |
| 2021 | $8,063 | 128 | UCB, Inc. ($5,111) |
All Payment Transactions
679 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 12/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: DERMATOLOGY | ||||||
| 12/16/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $7.20 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug), JUBLIA | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.42 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $21.29 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $11.98 | General |
| 11/21/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Inflammation & Immunology | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Immunology | ||||||
| 11/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.59 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Inflammation | ||||||
| 11/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.74 | General |
| Category: Immunology | ||||||
| 11/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.24 | General |
| Category: Immunology | ||||||
| 11/08/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $7.49 | General |
| Category: Immunology | ||||||
| 11/07/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $29.71 | General |
| Category: Dermatology | ||||||
| 11/07/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $4.34 | General |
| Category: Dermatology | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $1.15 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $28.72 | General |
| 11/06/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,181 | 1,962 | $464,062 | $70,334 |
| 2022 | 11 | 996 | 1,550 | $150,195 | $51,534 |
| 2021 | 16 | 1,275 | 2,075 | $194,868 | $68,108 |
| 2020 | 7 | 225 | 319 | $27,900 | $9,172 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 290 | 354 | $112,572 | $18,013 | 16.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 156 | 191 | $80,220 | $13,154 | 16.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 208 | 256 | $62,720 | $7,929 | 12.6% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 27 | 33 | $36,729 | $6,382 | 17.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 95 | 108 | $41,040 | $5,898 | 14.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 83 | 83 | $32,619 | $4,914 | 15.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 29 | 38 | $16,948 | $3,154 | 18.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 151 | 727 | $18,175 | $2,925 | 16.1% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 25 | 30 | $26,730 | $2,483 | 9.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 64 | 68 | $13,668 | $2,291 | 16.8% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 12 | 15 | $9,765 | $1,329 | 13.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 16 | 34 | $6,426 | $1,149 | 17.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 25 | 25 | $6,450 | $713.53 | 11.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 217 | 235 | $28,733 | $12,125 | 42.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 96 | 106 | $19,589 | $7,398 | 37.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 202 | 221 | $27,077 | $7,013 | 25.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 88 | 88 | $15,502 | $5,684 | 36.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 86 | 91 | $15,514 | $4,956 | 31.9% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 26 | 26 | $13,182 | $4,867 | 36.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 146 | 640 | $10,087 | $2,555 | 25.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 28 | 31 | $5,575 | $2,505 | 44.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 60 | 65 | $5,001 | $2,110 | 42.2% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2022 | 16 | 16 | $6,431 | $1,327 | 20.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 31 | 31 | $3,504 | $995.22 | 28.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 248 | 293 | $39,144 | $12,712 | 32.5% |
About Christopher Ney, PA-C
Christopher Ney, PA-C is a Physician Assistant healthcare provider based in Oviedo, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/04/2011. The National Provider Identifier (NPI) number assigned to this provider is 1376822668.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christopher Ney, PA-C has received a total of $25,128 in payments from pharmaceutical and medical device companies, with $3,514 received in 2024. These payments were reported across 679 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($10,269).
As a Medicare-enrolled provider, Ney has provided services to 3,677 Medicare beneficiaries, totaling 5,906 services with total Medicare billing of $199,148. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Other Specialties Physician Assistant
- Location Oviedo, FL
- Active Since 08/04/2011
- Last Updated 12/09/2025
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1376822668
Products in Payments
- Cimzia (Drug) $4,265
- TREMFYA (Drug) $2,100
- DUPIXENT (Biological) $1,098
- SKYRIZI (Biological) $794.68
- TargaDox (Drug) $643.77
- RINVOQ (Biological) $623.46
- Ximino (Drug) $500.00
- TALTZ (Drug) $470.87
- Sotyktu (Drug) $421.94
- REMICADE (Biological) $369.45
- Otezla (Drug) $324.25
- VTAMA (Drug) $306.42
- ADBRY (Biological) $230.63
- Bimzelx (Biological) $211.53
- COSENTYX (Biological) $209.38
- OPZELURA (Drug) $204.64
- COSENTYX (Drug) $194.69
- ILUMYA (Biological) $167.60
- Zoryve (Drug) $156.10
- EUCRISA (Drug) $155.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Oviedo
Vincent Polich, Pa, PA
Physician Assistant — Payments: $4,755
Ms. Sari Stender, P.a, P.A
Physician Assistant — Payments: $3,416
Ms. Yusrah Al-Deek, Pa-C, PA-C
Physician Assistant — Payments: $1,726
Kaitlyn De Leon
Physician Assistant — Payments: $510.05
Joanna Kluger-Wesley
Physician Assistant — Payments: $354.20
Kylie Broskus, Pa-C, PA-C
Physician Assistant — Payments: $267.76